Dr. Hingge Hsu is a co-founder of LifeMine and a senior advisor at WuXi Healthcare Ventures. Dr. Hsu brings more than twenty-five years of experience in venture capital and investment banking as well as corporate and business development.

Prior to WuXi, Dr. Hsu was a partner at Fidelity Biosciences, where he was involved with various venture stage investments in the biotechnology and medical technology sectors in the United States and Asia. Before Fidelity, Dr. Hsu was a managing director in the Private Equity Group at Lehman Brothers and was responsible for their principal investment activities in the private and public sectors of the healthcare industry. From 1998 to 2001 he held the position of partner at Schroder Ventures Life Sciences and directed their U.S. investment activities in the life sciences and therapeutics sectors.

Dr. Hsu holds an M.D. from Yale University School of Medicine, an M.B.A. from Harvard Business School, and received internal medicine training at Brigham and Women’s Hospital and Harvard Medical School.